IPO

IPO Synopsis

Medplus Health Services Ltd
Registered Office: 707 7th Floor 5-9-13 Saifabad,Taramandal Commercial Complex , Hyderabad - 500004 , Telangana , India.
Phone : 91-040-6724 6724   Fax:
Email :  cs@medplusindia.com; ir@medplusindia.com  
Website :  www.medplusindia.com
Initial public offering of 17,573,342* equity shares of face value of Rs2 each ("Equity Shares") of Medplus Health Services Limited (The "Company" or the "Company" or the "Issuer") for cash at a price of Rs796 per equity share (including a premium of Rs794 per equity share) ("Offer Price") aggregating to Rs1398.30 crores (The "Offer"), comprising of a fresh issue of 7,544,511 equity shares aggregating to Rs600.00 crores (The "Fresh Issue") by the company and an offer for sale of 10,028,831 equity shares aggregating to Rs798.30 crores (The "Offer for Sale"), comprising of 7,826,626 equity shares aggregating to Rs623.00 crores by PI Opportunities Fund - I ("Investor Selling Shareholder"), 1,344,221 equity shares aggregating to Rs107.00 crores by S. S. Pharma LLC, 402,010 equity shares aggregating to Rs32.00 crores by Shore Pharma LLC, 125,628 equity shares aggregating to Rs10.00 crores by Natco Pharma Limited, 125,628 equity shares aggregating to Rs10.00 crores by Time Cap Pharma Labs Private Limited, 89,547 equity shares aggregating to Rs7.13 crores by A. Raghava Reddy, 53,115 equity shares aggregating to Rs4.23 crores by K. Prakurthi, 27,135 equity shares aggregating to Rs2.16 crores by Navdeep Patyal, 18,467 equity shares aggregating to Rs1.47 crores by Sangeeta Raju, 14,974 equity shares aggregating to Rs1.19 crores by R. Venkat Reddy, 276 equity shares aggregating to Rs0.02 crores by TK Kurien, 251 equity shares aggregating to Rs0.02 crores by Nithya Venkataramani, 251 equity shares aggregating to Rs.0.02 crores by Atul Gupta, 251 equity shares aggregating to Rs0.02 crores by Manoj Jaiswal, 251 equity shares aggregating to Rs0.02 crores by Rahul Garg, 100 equity shares aggregating to Rs0.008 crores by Kollengode Ramanathan Lakshminarayana and 100 equity shares aggregating to Rs0.008 crores by Bijou Kurien (collectively, the "Other Selling Shareholders" and collectively with the investor selling shareholder are referred to as the "Selling Shareholders") and such equity shares, the "Offered Shares"). The offer includes a reservation of 69,637 equity shares, aggregating up to Rs5.00 crores (constituting up to 0.06% of the post-offer paid-up equity share capital), for subscription by eligible employees (as defined hereinafter) ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The company and the investor selling shareholder may, in consultation with the book running lead managers, offer a discount of 9.80 to the offer price to eligible employees bidding in the employee reservation portion ('Employee Discount"). The offer and the net offer shall constitute 14.72% and 14.67%, respectively, of the post-offer paid-up equity share capital of the "Company"). The face value of equity shares is Rs2 each. The offer price is 398 times the face value of the equity shares. *Subject to finalisation of the basis of allotment. #A discount of Rs78 per equity share was offered to eligible employees bidding in the employee reservation portion. Bids can be made for minimum 18 equity shares and in multiples of 18 equity shares thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
13-Dec-21 15-Dec-21 Rs 796.00-0.00 Rs 0.00-0.00
Minimum Application for shares in Nos :18  Further Multiples of :18
  (Rs Cr) Lead Managers to the Issue
Project Cost 600.00
Axis Capital Ltd
Project Financed through Current Offer 1398.30
Post Issue Equity Share Capital 23.86
Issue Price Rs 796.00
Projects
Funding Working Capital Requirements of the Material Subsidiary, Optival General Corporate Purposes
Promoted By Listing At Registrar to the Issue
  Gangadi Madhukar Reddy
  Lone Furrow Investments Pvt Lt
  Agilemed Investments Pvt Ltd
 BSE
 NSE
No Data Found.

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)